141 related articles for article (PubMed ID: 38289416)
1. CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn's disease resistant to infliximab.
Wang Y; Luo Z; Zhou Z; Zhong Y; Zhang R; Shen X; Huang L; He W; Lin J; Fang J; Huang Q; Wang H; Zhang Z; Mao R; Feng ST; Li X; Huang B; Li Z; Zhang J; Chen Z
Insights Imaging; 2024 Jan; 15(1):28. PubMed ID: 38289416
[TBL] [Abstract][Full Text] [Related]
2. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
[TBL] [Abstract][Full Text] [Related]
5. CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn's disease.
Yang T; Feng J; Yao R; Feng Q; Shen J
Insights Imaging; 2024 Mar; 15(1):69. PubMed ID: 38472447
[TBL] [Abstract][Full Text] [Related]
6. A novel clinical radiomics nomogram at baseline to predict mucosal healing in Crohn's disease patients treated with infliximab.
Zhu C; Hu J; Wang X; Li C; Gao Y; Li J; Ge Y; Wu X
Eur Radiol; 2022 Oct; 32(10):6628-6636. PubMed ID: 35857074
[TBL] [Abstract][Full Text] [Related]
7. CT enterography-based radiomics combined with body composition to predict infliximab treatment failure in Crohn's disease.
Song F; Ma M; Zeng S; Shao F; Huang W; Feng Z; Rong P
Radiol Med; 2024 Feb; 129(2):175-187. PubMed ID: 37982937
[TBL] [Abstract][Full Text] [Related]
8. Intestinal fibrosis classification in patients with Crohn's disease using CT enterography-based deep learning: comparisons with radiomics and radiologists.
Meng J; Luo Z; Chen Z; Zhou J; Chen Z; Lu B; Zhang M; Wang Y; Yuan C; Shen X; Huang Q; Zhang Z; Ye Z; Cao Q; Zhou Z; Xu Y; Mao R; Chen M; Sun C; Li Z; Feng ST; Meng X; Huang B; Li X
Eur Radiol; 2022 Dec; 32(12):8692-8705. PubMed ID: 35616733
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients.
Zhu C; Wang X; Wang S; Hu J; Gao Y; Li C; Li J; Wu X
Heliyon; 2023 Apr; 9(4):e14594. PubMed ID: 37151630
[TBL] [Abstract][Full Text] [Related]
10. Infliximab response associates with radiologic findings in bio-naïve Crohn's disease.
Yueying C; Jing F; Qi F; Jun S
Eur Radiol; 2023 Aug; 33(8):5247-5257. PubMed ID: 36928565
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
Li X; Liang D; Meng J; Zhou J; Chen Z; Huang S; Lu B; Qiu Y; Baker ME; Ye Z; Cao Q; Wang M; Yuan C; Chen Z; Feng S; Zhang Y; Iacucci M; Ghosh S; Rieder F; Sun C; Chen M; Li Z; Mao R; Huang B; Feng ST
Gastroenterology; 2021 Jun; 160(7):2303-2316.e11. PubMed ID: 33609503
[TBL] [Abstract][Full Text] [Related]
12. A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn's Disease.
Chen Y; Li H; Feng J; Suo S; Feng Q; Shen J
J Inflamm Res; 2021; 14():2731-2740. PubMed ID: 34194236
[TBL] [Abstract][Full Text] [Related]
13. A Novel Radiomics Model Integrating Luminal and Mesenteric Features to Predict Mucosal Activity and Surgery Risk in Crohn's Disease Patients: A Multicenter Study.
Ruiqing L; Jing Y; Shunli L; Jia K; Zhibo W; Hongping Z; Keyu R; Xiaoming Z; Zhiming W; Weiming Z; Tianye N; Yun L
Acad Radiol; 2023 Sep; 30 Suppl 1():S207-S219. PubMed ID: 37149448
[TBL] [Abstract][Full Text] [Related]
14. CT radiomics model for predicting the Ki-67 proliferation index of pure-solid non-small cell lung cancer: a multicenter study.
Liu F; Li Q; Xiang Z; Li X; Li F; Huang Y; Zeng Y; Lin H; Fang X; Yang Q
Front Oncol; 2023; 13():1175010. PubMed ID: 37706180
[TBL] [Abstract][Full Text] [Related]
15. A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study.
Dai Y; Cheng Y; Zhou Z; Li Z; Luo Y; Qiu H
PeerJ; 2023; 11():e16230. PubMed ID: 37849829
[TBL] [Abstract][Full Text] [Related]
16. CT-based whole lung radiomics nomogram: a tool for identifying the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.
Lin X; Zhou T; Ni J; Li J; Guan Y; Jiang X; Zhou X; Xia Y; Xu F; Hu H; Dong Q; Liu S; Fan L
Eur Radiol; 2024 Jan; ():. PubMed ID: 38216755
[TBL] [Abstract][Full Text] [Related]
17. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
Li L; Wang L; Zeng F; Peng G; Ke Z; Liu H; Zha Y
Eur Radiol; 2021 Oct; 31(10):7901-7912. PubMed ID: 33786655
[TBL] [Abstract][Full Text] [Related]
18. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
Beltrán B; Iborra M; Sáez-González E; Marqués-Miñana MR; Moret I; Cerrillo E; Tortosa L; Bastida G; Hinojosa J; Poveda-Andrés JL; Nos P
Dig Dis; 2019; 37(2):108-115. PubMed ID: 30149385
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nonenhanced CT based radiomics model to detect brown adipose tissue.
Li J; Zuo R; Schoepf UJ; Griffith JP; Wu S; Zhou C; Chen X; Tan W; Zhou Z; Gao H; Zhang L; Yang G
Theranostics; 2023; 13(5):1584-1593. PubMed ID: 37056567
[No Abstract] [Full Text] [Related]
20. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.
Cao WT; Huang R; Liu S; Fan YH; Xu MS; Xu Y; Ni H
World J Gastroenterol; 2022 Jun; 28(23):2582-2596. PubMed ID: 35949356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
